Hereditary Motor and Sensory Neuropathy IB (HMSN IB)

Other names
Types
Causes
Symptoms
Diagnostic tests
Non-pharmacological treatments (therapies and other care)
Drug treatments for symptoms
Dietary molecular supplements (supportive, not curative)
Regenerative, immunity-boosting and stem-cell approaches
Surgical treatments
Prevention and lifestyle tips
When to see doctors
What to eat and what to avoid
Frequently asked questions (FAQs)

Hereditary motor and sensory neuropathy IB (HMSN IB) is another name for Charcot–Marie–Tooth disease type 1B (CMT1B). It is a rare, inherited nerve disease that slowly damages the long nerves in the arms and legs. These nerves normally carry movement messages (motor) and feeling messages (sensory) between the brain, spinal cord, and limbs. In HMSN IB, the insulating coat of the nerve (called myelin) is damaged, so signals travel more slowly and less strongly. This leads to weakness of the feet and hands, changes in the shape of the feet, loss of feeling, problems with balance, and difficulty walking over time. NCBI+1

Hereditary motor and sensory neuropathy Ib is another name for Charcot-Marie-Tooth disease type 1B (CMT1B). It is a genetic nerve disease. It mainly affects the peripheral nerves, which carry signals from the spinal cord to the muscles and back from the skin to the brain. The problem is in the myelin sheath, the “insulation” around the nerve. In CMT1B, there is a change (mutation) in the MPZ gene, which makes a protein called myelin protein zero. This abnormal protein makes the myelin weak, so signals travel slowly and can be blocked. MalaCards+4NCBI+4Muscular Dystrophy Association+4

Because the nerves do not work well, muscles in the feet, legs, and later in the hands become weak and thin. People often have foot drop, high-arched feet, claw toes, tripping, balance problems, and reduced feeling in the feet and hands. Reflexes may be weak or absent. Hearing or vision can be affected in some families, but this is less common. The disease is slowly progressive and usually life-long, but many people can stay active with good supportive care. NCBI+2ScienceDirect+2

Other names

Doctors and books use many different names for this same condition. Knowing the other names helps you recognize it when you read medical texts. Common alternative names include: Charcot–Marie–Tooth disease type 1B (CMT1B), Charcot–Marie–Tooth disease, demyelinating, type 1B, hereditary motor and sensory neuropathy 1B, hereditary motor and sensory neuropathy IB, peroneal muscular atrophy, and “demyelinating CMT linked to the MPZ gene.” All of these labels describe the same basic problem: an inherited damage of the myelin around peripheral nerves that mainly affects movement and sensation in the limbs. NCBI+1

Types

Doctors do not usually split HMSN IB into many formal types, but they do describe patterns or sub-groups based on age at first symptoms and how severe the disease is. These “types” are more like clinical patterns than totally different diseases. Genetic Diseases Info Center+1

Early-infantile severe type (Dejerine–Sottas–like form)
In this pattern, symptoms start in the first years of life. Babies may be late to sit, stand, or walk. When nerve tests are done, nerve conduction is very slow, showing severe damage to the myelin. This picture overlaps with a severe childhood neuropathy called Dejerine–Sottas syndrome. Children in this group often need braces or a wheelchair earlier in life, and they may have more obvious muscle wasting and severe foot deformities. Genetic Diseases Info Center+1
Childhood-onset “classic CMT” type
In this group, children walk at more or less normal ages, but weakness in the legs, high-arched feet, and frequent trips or falls start in school years or teenage years. The course is slow and long-term. Nerve conduction is clearly slow (demyelinating), but not as extremely slow as in the infantile group. These children often show the familiar “inverted champagne bottle” shape of the lower legs because of muscle loss in the calves. NCBI+1
Adult-onset mild type
Some people do not notice clear problems until their 30s, 40s, or even later. They may present with foot weakness, repeated ankle sprains, or hand weakness when using tools. Nerve conduction is usually mildly to moderately slow, and symptoms progress slowly over decades. These people can stay independent for a long time but may still develop foot deformities and balance problems. Genetic Diseases Info Center+1
MPZ-mutation–specific patterns
Different changes (mutations) in the MPZ gene can cause slightly different patterns. Some mutations are linked to very early and severe disease, while others cause late and mild disease. Doctors sometimes group patients by mutation type when studying the disease, but in daily life, the important thing for patients is the degree of weakness, sensory loss, and disability, not the exact mutation label. MDPI+1

Causes

HMSN IB is mainly a genetic disease. The basic cause is a change in a gene, but many details can modify how the disease looks and how severe it becomes. Below are 20 causes or contributing factors explained in simple words.

MPZ gene mutation (main cause)
The core cause of HMSN IB is a mutation (change) in the MPZ gene, which gives instructions to make myelin protein zero, a key building block of the myelin coat in peripheral nerves. When this protein is abnormal, the myelin becomes unstable and nerve signals slow down. MDPI+1
Autosomal dominant inheritance
HMSN IB most often follows an autosomal dominant pattern. This means one changed copy of the MPZ gene from either parent is enough to cause the disease. A parent with the mutation has a 50% chance of passing it to each child. NCBI+1
Missense mutations in MPZ
Many MPZ changes are “missense” mutations, where one building block of the protein is swapped for another. Even this small change can alter protein shape, reduce its ability to form normal myelin, and lead to chronic demyelinating neuropathy. MDPI+1
Truncating or nonsense MPZ mutations
Some MPZ mutations create a shortened, incomplete protein. These “truncating” or “nonsense” changes can severely disturb myelin and cause earlier and more severe disease, often in childhood. MDPI+1
Frameshift MPZ mutations
A frameshift mutation changes the reading frame of the gene, producing a long chain of wrong amino acids. This type of change often leads to misfolded protein and strong stress inside Schwann cells, which damages myelin. MDPI+1
Protein misfolding and endoplasmic reticulum (ER) stress
Misfolded MPZ protein can build up inside Schwann cells and trigger the unfolded protein response. This stress response tries to protect the cell, but when it is constant, it can damage the cell and its myelin, worsening the neuropathy. MDPI
Faulty transport of MPZ protein
Some MPZ mutations cause the protein to be made but not correctly sent to the myelin sheath surface. Instead, it gets stuck inside the cell. Without enough MPZ at the myelin membrane, the sheath is thin or unstable, and nerve conduction becomes slow. MDPI+1
Abnormal adhesion between myelin layers
MPZ acts like a “glue” between layers of myelin. Changes in its structure can weaken this adhesion, leading to myelin splitting, folding, or peeling away from the nerve, all of which impair signal conduction. PMC+1
Focally folded myelin
Some MPZ mutations are linked with “focally folded myelin,” where sections of the myelin wrap fold in on themselves. This abnormal structure is seen on nerve biopsies and reflects severe local myelin damage, contributing to weakness and sensory loss. Springer+1
De novo mutations (new in the child)
Not every patient has a clear family history. Some people have a new MPZ mutation that appears in them for the first time. They can still pass it on to their children in an autosomal dominant pattern. NCBI+1
Modifier genes
Other genes that affect myelin health, nerve repair, or stress handling can modify how severe HMSN IB is. While the core cause is MPZ, modifier genes may explain why some people with the same mutation are milder or more severe than relatives. NCBI+1
Chronic demyelination-remyelination cycles
Over time, Schwann cells repeatedly lose and rebuild myelin because of the abnormal MPZ protein. Each cycle may leave the nerve a little more damaged, and this chronic process contributes to gradual progression of weakness and sensory loss. NCBI+1
Axonal loss secondary to myelin damage
Long-term myelin injury can eventually harm the underlying axon (the nerve fiber itself). Once axons are lost, muscles and sensory areas lose their connection permanently, leading to fixed weakness and numbness. NCBI+1
Length-dependent vulnerability of long nerves
The longest nerves, such as those going to the feet, are most vulnerable to demyelination and axonal damage. This is why symptoms usually start in the feet and legs and only later affect the hands. The length-dependent nature of the neuropathy is a key “cause” of the distal pattern of symptoms. NCBI+1
Family history of CMT or HMSN
Having parents or relatives with CMT or HMSN is itself a causal background factor, because it means the family carries MPZ or other CMT gene mutations. Family history is a strong clue for diagnosis, and it reflects inherited genetic risk. PM&R KnowledgeNow+1
Genetic background of different populations
Certain MPZ mutations may be more common in specific ethnic groups or regions. Local founder mutations can lead to clusters of cases in particular families or communities, shaping how often HMSN IB appears in that area. Neurology Asia+1
Age-related nerve changes
Normal aging already brings some nerve slowing. In a person with HMSN IB, aging may add to the genetic problem, making weakness, balance difficulties, and sensory loss more noticeable in middle age and later life. NCBI+1
Mechanical stress on weak feet and ankles
Because nerves are weak, muscles that support the foot and ankle are also weak. Over time, walking on unstable joints and abnormal foot shapes can cause extra strain, which worsens pain, deformities, and disability. This mechanical stress does not cause HMSN IB itself but adds to its impact. Apollo Hospitals+1
Secondary complications such as contractures
Tight tendons and joint contractures can appear as muscles weaken. These secondary changes further reduce movement and worsen balance, indirectly increasing disability from the underlying neuropathy. PFM Journal+1
Delayed diagnosis and lack of early support
HMSN IB is rare, so diagnosis can be late. Without early braces, therapy, and education, people may fall more, develop more severe deformities, and experience more joint damage. While this does not cause the genetic disease, it clearly worsens the final outcome, so early recognition is important. ScienceDirect+1

Symptoms

Symptoms of HMSN IB are similar to other forms of Charcot–Marie–Tooth disease, but can vary in age of onset and severity. They mainly involve weakness, sensory loss, and deformities in the feet and hands. NCBI+1

Weakness in the feet and ankles
One of the first signs is often weakness in the muscles that lift the front of the foot. This can cause the toes to drag and the person to trip easily. Over time, other muscles in the lower leg become weak, making it harder to walk long distances or run. Mayo Clinic+1
High-arched feet (pes cavus)
Many people develop high arches because some foot muscles become weak while others stay relatively strong, pulling the foot into an abnormal shape. High arches can cause pressure points, foot pain, calluses, and difficulty finding comfortable shoes. Mayo Clinic+1
Hammertoes or claw toes
Toes may bend at the joints and become fixed in a claw-like shape. This comes from imbalanced muscle forces around the toes and is seen often in hereditary neuropathies. These deformities can rub inside shoes and lead to pain and skin breakdown. Mayo Clinic+1
Frequent tripping and falls
Because of foot drop and poor balance, people with HMSN IB often trip on small obstacles, uneven ground, or carpet edges. Falls become more common, especially in dim light or when walking quickly. Mayo Clinic+1
Wasting of lower leg muscles (“stork legs”)
Muscles in the front and sides of the lower legs gradually shrink, giving a thin, “inverted champagne bottle” or “stork leg” appearance. This is due to chronic denervation of the muscles as nerves lose function. NCBI+1
Loss of feeling in feet and toes
Numbness, reduced ability to feel touch, pain, or temperature, and a “sock-like” area of reduced sensation are common. When people cannot feel the ground well, balance becomes worse, and unnoticed injuries may occur. Mayo Clinic+1
Pins and needles or burning pain
Some people feel tingling, pins and needles, or burning in their feet or hands. This neuropathic pain can be mild or severe and may be worse at night, disturbing sleep. ninds.nih.gov+1
Weakness in hands and fingers
As the disease progresses up the limbs, the small muscles in the hands may weaken. People may notice trouble with buttons, zippers, handwriting, or fine tasks like opening jars and using tools. NCBI+1
Reduced or absent reflexes (areflexia)
On examination, doctors often find that tendon reflexes at the ankles and knees are reduced or absent. This is a typical sign of peripheral neuropathy and helps distinguish it from brain or spinal cord problems. PM&R KnowledgeNow+1
Gait problems and poor balance
People may walk with a “steppage gait,” lifting the knees higher to avoid dragging the toes. Balance is often worse in the dark or when standing with feet together, because sensory feedback from the feet is reduced. NCBI+1
Fatigue and reduced stamina
Walking or standing for long periods may be tiring because weak muscles must work harder to perform daily activities. People often need more rest breaks and may avoid long walks or sports because of fatigue. ninds.nih.gov+1
Foot and ankle pain from deformity
Pain may come from abnormal foot structure, pressure from shoes, and strain on ligaments, rather than only from nerve pain. Orthopedic pain can limit activity even when nerve symptoms are stable. Apollo Hospitals+1
Scoliosis or spine curvature in some patients
In some people, especially with early and severe disease, the spine may curve (scoliosis). This is thought to be related to muscular imbalance and connective tissue changes and is reported in some CMT cohorts. NCBI+1
Hearing problems or pupillary abnormalities (in some CMT1B)
Certain MPZ mutations in CMT1B have been associated with hearing loss or eye pupil changes, especially in adults with late-onset disease. These features are not present in everyone but are important clues in specific families. Genetic Diseases Info Center+1
Emotional stress and reduced quality of life
Living with a long-term, slowly progressive nerve disease can cause worry, sadness, or anxiety about future disability. Mobility limits, need for braces, and social problems around walking or hand function can all affect mental health and quality of life. ninds.nih.gov+1

Diagnostic tests

Doctors use a mix of clinical examination, nerve tests, genetic tests, and imaging to diagnose HMSN IB and to rule out other causes of neuropathy. Below, the tests are grouped into physical exam, manual tests, lab/pathological, electrodiagnostic, and imaging tests.

Physical examination tests

General neurological examination
The neurologist looks at muscle bulk, strength, tone, reflexes, and sensation in all four limbs. In HMSN IB, they usually find distal muscle wasting, reduced strength at the ankles and hands, decreased reflexes, and a “stocking-glove” pattern of sensory loss. This structured exam is the first step to suspect a hereditary neuropathy. PM&R KnowledgeNow+1
Gait observation and functional walking tests
The doctor watches the person walk normally, on heels, on toes, and in a straight line. A high-stepping gait, difficulty heel-walking, and frequent tripping suggest foot drop from distal neuropathy. Gait observation also helps decide if orthoses or walking aids are needed. Orthobullets+1
Foot and posture examination
The clinician inspects feet for high arches, flat feet, hammertoes, calluses, and ankle instability. They also look for scoliosis or other skeletal deformities. These structural signs are very common in CMT and give strong support to the diagnosis. Mayo Clinic+1
Family examination and pedigree assessment
When possible, the doctor may examine close relatives and draw a family tree to see who else is affected. A pattern of neuropathy in multiple generations supports autosomal dominant inheritance and helps distinguish HMSN IB from acquired neuropathies such as diabetic neuropathy. NCBI+1

Manual tests

Manual muscle testing (MMT)
The clinician grades strength in specific muscles (for example ankle dorsiflexors, toe extensors, hand interossei) on a 0–5 scale. In HMSN IB, weakness is usually worse in distal muscles than in proximal ones. Serial MMT helps track disease progression and plan therapy and bracing. PM&R KnowledgeNow+1
Manual sensory testing (light touch, pinprick, vibration)
Using cotton, a blunt pin, or a tuning fork, the examiner tests feeling in the feet, legs, hands, and arms. Reduced vibration at the big toe, numbness to light touch, or decreased pinprick in a stocking-glove pattern are typical findings in hereditary motor and sensory neuropathies. NCBI+1
Romberg and balance tests
The Romberg test asks the person to stand with feet together, first with eyes open and then closed. People with loss of position sense in their feet may sway or fall when they close their eyes. This simple bedside test highlights sensory ataxia from peripheral neuropathy. NCBI+1
Heel-toe walking and tandem gait
The person is asked to walk on a narrow line, placing one foot directly in front of the other. Difficulty with tandem gait suggests problems with balance, distal weakness, or both, and supports the presence of a significant neuropathy. PM&R KnowledgeNow+1

Laboratory and pathological tests

Basic blood tests to rule out acquired neuropathy
Although blood tests do not diagnose HMSN IB directly, doctors usually check glucose, vitamin B12, thyroid function, kidney function, and other markers to rule out common acquired neuropathies. Finding normal results supports the idea of an inherited cause when combined with family history and exam findings. NCBI+1
Genetic testing for MPZ mutations
Once clinical features and nerve conduction studies suggest demyelinating CMT, targeted genetic testing is used. Panels or whole-exome tests can look for mutations in MPZ and other CMT genes. Finding a pathogenic MPZ mutation confirms HMSN IB/CMT1B at the molecular level. ScienceDirect+1
Expanded CMT gene panel testing
If a single-gene test is negative, many centers use multigene panels or next-generation sequencing to search for a broader range of CMT-related genes. This helps rule out other forms like CMT1A, CMT2, or CMTX and ensures the correct subtype is identified when possible. NCBI+1
Peripheral nerve biopsy (rarely needed)
In uncertain cases, a small segment of a sensory nerve may be removed for microscopic study. In HMSN IB, the biopsy can show demyelination, remyelination, and sometimes focally folded myelin. Because biopsy is invasive and genetic tests are now widely available, it is reserved for special situations. PMC+1

Electrodiagnostic tests

Nerve conduction studies (NCS)
NCS measure how fast and how strongly nerves conduct electrical signals. In HMSN IB, motor and sensory conduction velocities are typically slow, showing a demyelinating pattern. This test is central in classifying CMT into demyelinating (type 1) versus axonal (type 2) forms. PMC+1
Electromyography (EMG)
EMG uses a needle electrode to record activity from muscles. In hereditary neuropathy, EMG may show chronic denervation and re-innervation patterns but usually no signs of primary muscle disease. EMG, together with NCS, helps confirm that the problem is in peripheral nerves. PMC+1
F-wave and late response studies
F-waves are late responses that reflect conduction in the most proximal segments of motor nerves. In demyelinating neuropathies like HMSN IB, F-wave latency is often prolonged, showing that slow conduction affects the whole length of the nerve, not just the distal part. PMC+1
Somatosensory evoked potentials (SSEPs) in selected cases
SSEPs measure how sensory signals travel from a nerve in the limb, through the spinal cord, to the brain. They may be used in research or special clinical cases to assess the full sensory pathway and can show delayed conduction in hereditary neuropathies, although they are not required in every patient. Neurology Asia+1

Imaging tests

X-rays of feet and ankles
Simple X-rays can document high arches, hammertoes, joint deformities, or early arthritis. These images guide orthopedic and surgical planning and provide a baseline to follow structural change over time, even though they do not show nerve damage directly. Orthobullets+1
Spine X-rays for scoliosis
If the doctor suspects scoliosis, standing spine X-rays are done to measure curves and monitor progression. This is important because severe spinal curves can cause pain, breathing problems, and further disability if not treated. NCBI+1
MRI or ultrasound of peripheral nerves (neuromuscular imaging)
In some centers, MRI or high-resolution ultrasound is used to look at nerve size and structure. In demyelinating CMT, nerves may be enlarged or show characteristic patterns. These imaging tools are especially helpful when the diagnosis is uncertain or when surgeons plan nerve decompression. Cleveland Clinic+1
Brain and spinal MRI to exclude other causes
If symptoms are unclear or if there are signs that suggest central nervous system disease (such as brisk reflexes or brain symptoms), doctors may order MRI of the brain or spine. A normal MRI in a person with clear peripheral neuropathy features supports a diagnosis like HMSN IB rather than a brain or spinal cord disorder. NCBI+1

Non-pharmacological treatments (therapies and other care)

They do not cure hereditary motor and sensory neuropathy Ib, but they can protect joints, improve walking, and reduce pain.

Physiotherapy (physical therapy)
Physiotherapy uses stretching, strengthening, balance and gait training. The purpose is to keep muscles as strong and flexible as possible, improve walking pattern, and reduce risk of falls. Exercises are usually low-impact, for example stationary cycling, water exercise, or gentle resistance bands. The therapist adjusts the plan to avoid over-fatigue, because very hard exercise can overwork weak muscles. Physiopedia+2ScienceDirect+2
Occupational therapy
Occupational therapists help with hand weakness, fine motor tasks, school and work activities. The purpose is to keep independence in self-care and daily tasks. They may teach energy-saving strategies, suggest adaptive tools (built-up pens, special cutlery, button hooks), and modify the home or classroom to reduce tripping and falling.
Ankle-foot orthoses (AFOs)
AFOs are light braces worn inside or over shoes to hold the ankle in a stable position and lift the front of the foot. They reduce foot drop, improve step clearance, and help with balance. The mechanism is simple: the brace mechanically supports weak muscles and keeps the ankle at a safer angle. Correctly fitted AFOs reduce fatigue and risk of ankle sprain. cmtausa.org+2Pod NMD+2
Custom footwear and insoles
Special shoes and insoles can support high arches and claw toes, improve pressure distribution, and reduce calluses and ulcers. The purpose is to protect skin with reduced sensation and to stabilize the foot during walking. Extra-depth shoes can also fit AFOs comfortably and reduce rubbing.
Stretching programs
Daily stretching of calves, hamstrings, hip muscles, and toes helps prevent contractures (permanent shortening of muscles and tendons). The purpose is to keep joints moving freely so that walking remains more efficient. The mechanism is gentle, regular elongation of muscles and connective tissue to counteract tightness from chronic weakness.
Balance and fall-prevention training
Many people with CMT1B have poor proprioception (joint position sense). Therapists can use balance boards, tandem walking, and safe balance tasks to train the brain to use vision and remaining sensation better. The goal is fewer falls and more confidence in daily life.
Hand and grip training
Weakness of small hand muscles leads to poor grip and fine motor skills. Exercises with soft balls, therapy putty, and pinch devices can slow loss of hand function. The purpose is to maintain independence in writing, using a phone, or doing hobbies. Splints may be used to prevent deformities.
Hydrotherapy / aquatic therapy
Water supports body weight, so movement is easier. Aquatic therapy lets people practice walking, balance, and gentle strengthening with less stress on joints and less fear of falling. Warm water also relaxes tight muscles. The mechanism is buoyancy plus gentle resistance from water.
Podiatry (foot care)
Regular visits to a podiatrist help manage calluses, ingrown nails, and skin breakdown, especially because sensation is reduced. The purpose is to prevent ulcers and infections, which can become serious if unnoticed. Podiatrists also advise on footwear and monitor for deformities.
Pain psychology and coping skills
Chronic pain and fatigue can cause anxiety, low mood, and sleep problems. Cognitive-behavioural therapy (CBT), relaxation training, and mindfulness can reduce the suffering linked with pain. The mechanism is not to stop pain signals but to change how the brain responds, reducing stress and improving sleep.
Education about joint protection
Learning how to lift correctly, avoid twisting ankles, and pace activity can protect joints and ligaments. People are taught to avoid walking on uneven ground without support, and to use railings on stairs. The purpose is to prevent injuries, which may take longer to heal in weak muscles.
Energy conservation and fatigue management
Many people with hereditary motor and sensory neuropathy Ib feel tired easily. Therapists teach “pacing”: planning rest breaks, alternating heavy and light tasks, and using assistive devices when needed. This keeps people active without over-exertion that could worsen weakness.
Use of canes, walking sticks, or walkers
When balance is poor, a cane or walker can give an extra point of support. The purpose is to reduce falls and increase walking distance. The mechanism is simple: more contact points with the ground spread body weight and improve stability.
Home modifications
Simple changes like removing loose rugs, adding grab bars in bathrooms, better lighting, and using non-slip mats can make the home safer. This reduces tripping and allows more independence even when strength is limited.
School and workplace accommodations
Extra time to move between classes, access to elevators, ergonomic chairs, and flexible schedules can help students or workers with CMT1B remain productive. The purpose is to match the environment to the person’s physical limits, not to force the body beyond safe levels.
Orthopaedic monitoring in children
Children with hereditary motor and sensory neuropathy Ib should be checked regularly for scoliosis, hip problems, and foot deformities. Early detection allows bracing or minor procedures instead of later major surgery. Paediatric orthopaedic teams often work closely with neurologists. NCBI+1
Hearing and vision assessment where needed
Some families with MPZ mutations can have hearing loss. Regular audiology tests and early use of hearing aids or cochlear implants can greatly improve communication and learning. NCBI+1
Nutritional counselling
Maintaining a healthy weight is important. Extra weight makes walking harder and increases stress on weak ankles and knees. Dietitians can design meal plans that support energy without excess calories and ensure enough vitamins and minerals.
Peer support groups and patient organizations
Organisations such as CMT associations provide information, emotional support, and access to research updates and clinical trials. Talking with others who have CMT reduces isolation and helps families learn practical tips. cmtausa.org+1
Genetic counselling for families
Genetic counsellors explain inheritance patterns, risk to children, and options such as prenatal or pre-implantation genetic testing. The purpose is to help families make informed choices, reduce anxiety, and understand why the condition happened.

Drug treatments for symptoms

There is no drug that cures hereditary motor and sensory neuropathy Ib.
Medicines are used mainly for neuropathic pain, muscle cramps, mood, and sleep problems. Most of these drugs are approved by the FDA for other neuropathic pain disorders, such as diabetic neuropathy or post-herpetic neuralgia, and used off-label in CMT after careful risk–benefit discussion. Best Practice Advocacy Centre+3cmtausa.org+3PMC+3

Below are examples of important drug groups. Exact dose, timing, and choice must always be made by a specialist.

Gabapentin (e.g., Neurontin, Gralise)
Gabapentin is an anticonvulsant widely used for neuropathic pain. It binds to calcium channels in nerve cells and reduces release of pain-signalling neurotransmitters. In adults, FDA labels describe total daily doses up to about 3600 mg, divided in several doses, for neuropathic pain conditions. Common side effects are dizziness, sleepiness, weight gain, and swelling of legs. Doctors start with low doses and increase slowly, especially if kidney function is reduced. FDA Access Data+3FDA Access Data+3FDA Access Data+3
Pregabalin (e.g., Lyrica, Lyrica CR)
Pregabalin is similar to gabapentin and is FDA-approved for several neuropathic pain conditions. It reduces abnormal nerve firing by binding to the alpha-2-delta subunit of voltage-gated calcium channels. Adult neuropathic pain doses are often between 150 and 600 mg/day, in divided doses, according to the label. Side effects include dizziness, drowsiness, blurred vision, swelling, and weight gain. It is a controlled substance in some countries, so monitoring is important. Springer+5FDA Access Data+5FDA Access Data+5
Duloxetine (Cymbalta)
Duloxetine is a serotonin–norepinephrine reuptake inhibitor (SNRI). It is FDA-approved for diabetic neuropathic pain, fibromyalgia, depression, and anxiety. It increases serotonin and norepinephrine in pain-modulating pathways in the brain and spinal cord, which reduces pain sensitivity. Typical adult doses for neuropathic pain in labels are about 60 mg/day. Common side effects are nausea, dry mouth, sleep changes, and sweating. It should not be stopped suddenly. Springer+6FDA Access Data+6FDA Access Data+6
Tricyclic antidepressants (e.g., amitriptyline, nortriptyline)
Tricyclics block reuptake of serotonin and norepinephrine and also block some pain-related ion channels. They are considered first-line options for neuropathic pain in adults, but they have more side effects, so low doses at night are often used. Side effects include dry mouth, constipation, weight gain, and drowsiness, and they can affect heart rhythm. Amitriptyline labels emphasise careful dose selection and caution in young people; paediatric use needs specialist supervision. Drugs.com+6PMC+6Springer+6
Other SNRIs (e.g., venlafaxine)
Venlafaxine also increases serotonin and norepinephrine in the central nervous system. It can reduce neuropathic pain intensity and improve mood in adults. Side effects may include nausea, sweating, small increases in blood pressure, and sleep changes. Dose and timing depend on the formulation (immediate vs extended release) and must be guided by a doctor.
Sodium-channel-blocking anticonvulsants (e.g., carbamazepine, oxcarbazepine, lamotrigine)
These drugs stabilize over-active nerve membranes by blocking voltage-gated sodium channels. They may help sharp, shooting or electric-shock-like neuropathic pain. Side effects include dizziness, drowsiness, rash, and, rarely, serious skin reactions or low sodium. Regular lab monitoring is often required.
Topical lidocaine (patches or gels)
Lidocaine patches placed over a painful area numb superficial nerves by blocking sodium channels locally. This avoids many whole-body side effects. Patches are usually applied for up to 12 hours a day over intact skin. Skin irritation is the most common problem. This can be a good option when pain is localized, such as on the top of the foot. PMC+1
Topical capsaicin (low- or high-dose creams/patches)
Capsaicin, from chilli peppers, over time depletes substance P and reduces pain signalling in nerve endings. High-dose patches are applied in specialist clinics for a short period; low-dose creams are used at home. Burning and redness are common at the beginning. This treatment is for adults and should be used with trained guidance. Springer+1
Short-term use of tramadol or other opioids (second-line)
Guidelines suggest that opioids are second- or third-line for neuropathic pain because of dependence and side effects. In some severe cases, doctors may use tramadol or other opioids for short periods. They act by binding to opioid receptors and sometimes also blocking serotonin and norepinephrine reuptake. Side effects include constipation, nausea, drowsiness, and risk of addiction. PMC+2Best Practice Advocacy Centre+2
Muscle relaxants for cramps (e.g., baclofen, tizanidine)
Some people with CMT1B get painful muscle cramps. Drugs like baclofen (a GABA-B agonist) or tizanidine (an alpha-2 agonist) can reduce spasticity or cramping in adults. However, they may cause weakness, drowsiness, or low blood pressure, so neurologists balance benefits and risks carefully.
Sleep and mood medicines when needed
Chronic pain and disability can cause insomnia and depression. Sometimes low-dose antidepressants or other sleep-supporting medicines are used, always with monitoring. Addressing mood and sleep can indirectly reduce pain intensity and improve quality of life.
Treatment of associated conditions (e.g., diabetes, thyroid disease)
If a person with CMT1B also has diabetes, thyroid problems, vitamin B12 deficiency, or autoimmune disease, these must be treated aggressively, because they can worsen neuropathy. Standard evidence-based guidelines are followed for each condition, with close monitoring of nerve symptoms.

Again, all medicines must be prescribed and adjusted only by doctors, especially in children and teenagers.

Dietary molecular supplements (supportive, not curative)

There is no supplement proven to cure hereditary motor and sensory neuropathy Ib. Some nutrients are important for general nerve health and overall wellbeing. Evidence is often limited or indirect (from other neuropathies). Doses below are typical adult ranges reported in studies or guidelines; they are not personal advice and may not be safe for everyone.

Vitamin B12 (cobalamin)
Vitamin B12 is essential for myelin and DNA synthesis. Deficiency can cause its own neuropathy. In people with low B12, replacement can improve nerve function. Oral doses in adults are often 500–1000 µg/day, or injections are used if absorption is poor. Mechanism: it supports methylation reactions needed for myelin repair. Levels should be checked before long-term use.
Vitamin B1 (thiamine) or benfotiamine
Thiamine is important for carbohydrate metabolism and nerve energy. Benfotiamine, a fat-soluble form, has been studied in diabetic neuropathy. Adult doses in studies are often 150–600 mg/day. Mechanism: it reduces formation of harmful advanced glycation end-products and supports nerve energy metabolism.
Vitamin B6 (pyridoxine – cautious use)
Normal B6 levels help nerve function, but high doses can actually cause neuropathy, so medical supervision is essential. If deficiency exists, small replacement doses (for example 25–50 mg/day in adults) may be used for a short time. Mechanism: co-factor in many neurotransmitter and metabolic pathways.
Alpha-lipoic acid
Alpha-lipoic acid is an antioxidant that regenerates other antioxidants like vitamin C and glutathione. Studies in diabetic neuropathy have shown improved burning pain and numbness. Oral doses around 600 mg/day are common in trials. Mechanism: reduces oxidative stress in nerves and improves blood flow.
Omega-3 fatty acids (fish oil, EPA/DHA)
Omega-3 fats are components of cell membranes and may reduce inflammation. Typical adult supplemental doses are 1–3 g/day of combined EPA/DHA, if not contraindicated. They may support vascular health and general nerve environment but are not a specific CMT therapy.
Vitamin D
Vitamin D is important for bone, muscle, and immune health. Low vitamin D can worsen muscle weakness and fall risk. Dosing depends on blood levels; adults may take 800–2000 IU/day, but lab monitoring is needed to avoid toxicity. Mechanism: regulates calcium, muscle function, and immune signalling.
Coenzyme Q10 (CoQ10)
CoQ10 is part of the mitochondrial electron transport chain and acts as an antioxidant. In theory it may support energy production in muscle and nerve. Adult doses in studies range from 100–300 mg/day. Evidence in hereditary neuropathies is limited, but some patients report reduced fatigue.
Acetyl-L-carnitine
This molecule helps transport fatty acids into mitochondria for energy. Some studies in chemotherapy-induced neuropathy suggest modest benefit. Adult doses used in studies are 1000–3000 mg/day in divided doses. Mechanism: supports mitochondrial function and may promote nerve regeneration.
Magnesium
Magnesium is involved in muscle relaxation and nerve conduction. If levels are low, cramps and fatigue can worsen. Supplements (for example 200–400 mg elemental magnesium/day in adults) can help, but high doses may cause diarrhoea and should be avoided in kidney disease.
Multivitamin and balanced micronutrient support
For people with limited diet or increased needs, a basic multivitamin/mineral can fill small gaps. The purpose is to prevent deficiencies that could worsen neuropathy, such as low folate, B12, or zinc. It should not be used as an excuse for poor diet.

Always check supplements with a doctor or pharmacist. Some can interact with prescription medicines or be unsafe in kidney, liver, or heart disease.

Regenerative, immunity-boosting and stem-cell approaches

For hereditary motor and sensory neuropathy Ib, no immune-boosting drug or regenerative stem-cell product is yet approved as a standard treatment. Research is very active, especially in CMT1A and other CMT types, and some trials may be relevant in the future.

Gene therapy trials
Researchers are testing gene therapies that deliver normal copies of genes or silence harmful ones using viral vectors such as adeno-associated virus (AAV). In animal models of CMT, these approaches improved myelin and nerve conduction. Doses and routes are still being studied and are only used in research settings. PMC+2Institut Myologie+2
Mesenchymal stem cell therapies (experimental)
Early-phase trials in CMT1A are exploring umbilical-cord-derived or mesenchymal stem cells to support nerve repair and reduce inflammation. One example is EN001, studied in Korea in people with CMT1A. These treatments are not yet standard care, and dosing is controlled by trial protocols, not by routine clinicians. cmtausa.org+2Cells4Life+2
Schwann-cell-targeted regenerative approaches
Some research uses cells or molecules aimed at supporting Schwann cells, the myelin-forming cells. The idea is to improve myelin thickness and stability. This may involve growth factors, modified stem cells, or biologic drugs. At present there are no approved Schwann-cell therapies for CMT1B.
Small-molecule therapies in trials
Clinical trials are ongoing for drugs that change myelin gene expression or protect nerves from stress. These may include neuroprotective agents, modulators of unfolded protein response, or lipid-modifying drugs. None are yet clearly proven or licensed for hereditary motor and sensory neuropathy Ib. ScienceDirect+2PMC+2
Immune-modulating drugs (not usually helpful in CMT1B)
Because CMT1B is a genetic myelin disease, standard immune-suppressing drugs (like steroids, IVIG, or rituximab) that treat autoimmune neuropathies do not usually help. They are reserved for people who also have a separate autoimmune neuropathy, which is rare and diagnosed by specialists.
Future combined gene + cell therapies
Scientists are exploring combinations where gene-corrected stem cells are used to repopulate or support damaged nerves. This is still at the laboratory or early-animal stage, not ready for patients. Long-term safety, dosing, and benefit need careful proof before everyday use. PMC+1

Be cautious about unregulated “stem-cell clinics” that advertise miracle cures on the internet. Many are not supported by real evidence and may be dangerous or extremely expensive.

Surgical treatments

Surgery does not cure hereditary motor and sensory neuropathy Ib, but it can correct structural problems caused by long-term muscle imbalance.

Foot deformity correction (osteotomy and soft-tissue balancing)
High-arched feet (pes cavus), claw toes, and heel deformity are common. Orthopaedic surgeons can cut and reposition bones (osteotomy), lengthen tight tendons, and transfer stronger tendons to replace weak ones. The purpose is to create a more plantigrade (flat, stable) foot that fits in shoes and AFOs, reduces pain, and prevents skin breakdown.
Tendon transfer procedures
In some cases, a working tendon (for example the posterior tibial tendon) is re-attached to help lift the foot, replacing weak muscles that normally do this job. This can improve foot clearance during walking and may reduce the need for bracing in selected patients.
Toe surgery for clawing
Claw toes can cause painful pressure points and ulcers. Surgeons may straighten toes by releasing tight tendons or fusing small joints. The aim is to fit shoes better and reduce pain and ulcer risk.
Ankle fusion (arthrodesis) in severe instability
When the ankle joint is very unstable and painful, and braces no longer help, fusion can make the joint solid and stable. This sacrifices some movement but may improve pain and standing stability.
Spinal surgery in severe scoliosis
If scoliosis becomes severe and continues to worsen, spinal fusion and instrumentation may be needed to prevent lung compromise and chronic pain. This is usually considered in teenagers or young adults with rapid curve progression and is planned very carefully.

Prevention and lifestyle tips

Hereditary motor and sensory neuropathy Ib itself cannot be prevented, because it is genetic. But many complications can be reduced:

Protect your feet every day – check skin for blisters or cuts, wear well-fitting shoes, and avoid walking barefoot.
Keep to a healthy body weight – extra weight makes walking harder and increases joint strain.
Stay active with safe exercise – gentle, regular movement is better than long periods of sitting plus sudden heavy activity.
Avoid smoking and limit alcohol – both can worsen nerve damage and circulation.
Manage other health problems well – especially diabetes, thyroid disease, and vitamin deficiencies.
Use braces or walking aids when recommended – early use often prevents falls and later joint damage.
Follow stretching routines – daily stretches reduce contractures and keep joints flexible.
Make home and school environments safer – good lighting, no loose rugs, and railings on stairs.
Attend regular follow-up with neurology and orthopaedics – early detection of new problems allows simpler treatment.
Consider genetic counselling for family planning – families can understand inheritance and options.

When to see doctors

You should see a doctor (ideally a neurologist or neuromuscular specialist) if any of the following happen:

New or rapidly worsening weakness, falls, or difficulty walking.
Sudden change in sensation, such as numbness rising higher up the legs or into the hands.
New severe pain, burning, or electric-shock sensations that do not improve.
Foot ulcers, wounds, or infections that do not heal quickly.
Problems with breathing, swallowing, or severe scoliosis symptoms such as shortness of breath on exertion.
Major mood changes, thoughts of self-harm, very poor sleep, or strong anxiety linked with the disease.
Any side effects from medicines, such as rash, swelling of the face or tongue, strong dizziness, chest pain, or thoughts of suicide – seek urgent care in those cases. FDA Access Data+3cmtausa.org+3PMC+3

Because you are a teenager, it is important that a parent or guardian goes with you and that your care team explains things in a way you can understand.

What to eat and what to avoid

What to eat more often

Balanced meals with whole grains, lean protein, and vegetables – support stable energy and healthy weight.
Foods rich in B-vitamins – such as eggs, fish, meat, dairy, leafy greens, and fortified cereals, to support nerve health.
Omega-3 sources – like oily fish (salmon, sardines) or, if appropriate, doctor-approved fish-oil supplements.
Fruit and colourful vegetables – provide antioxidants that may help reduce oxidative stress in nerves and muscles.
Adequate hydration – water throughout the day helps overall health and reduces constipation from some pain medicines.

What to limit or avoid

Excess alcohol – alcohol itself can damage nerves and worsen balance.
Sugary drinks and junk food – these promote weight gain and poor blood sugar control.
Very high doses of single vitamins without medical advice, especially vitamin B6 – too much can cause neuropathy.
Extreme low-carb or fad diets that may lead to vitamin and mineral deficiencies.
Energy drinks and high-caffeine products that disturb sleep, which is vital for coping with chronic disease.

A registered dietitian can give a personalized plan that fits your culture, preferences, and other medical needs.

Frequently asked questions (FAQs)

Is hereditary motor and sensory neuropathy Ib the same as Charcot-Marie-Tooth disease?
Yes. Hereditary motor and sensory neuropathy is an older name for Charcot-Marie-Tooth (CMT) disease. Type I refers to demyelinating forms, and subtype Ib corresponds to CMT1B, usually caused by MPZ gene mutations. MalaCards+3NCBI+3Muscular Dystrophy Association+3
Can CMT1B be cured?
At present there is no cure and no medicine that reverses the genetic change. Treatment is supportive and focuses on function, comfort, and preventing complications. Research in gene and cell therapy is ongoing and gives hope for future disease-modifying treatments. CMT Research Foundation+3ScienceDirect+3PMC+3
Will I end up in a wheelchair?
Many people with CMT1B remain walking for life, especially with early therapy and braces. Some may need a wheelchair or scooter for long distances or later in life. This varies widely between families and even between relatives with the same mutation.
Is exercise safe or harmful?
Gentle, regular exercise is usually helpful, but very intense over-loading can over-tire weak muscles. Physiotherapists experienced with neuromuscular diseases can design a safe program. Pain and unusual fatigue after exercise should be discussed with the therapist or doctor.
Can children with CMT1B play sports?
Many children can take part in adapted sports, such as swimming or cycling, with safety measures. Activities with high risk of ankle injury or falls (for example, contact sports) may need modifications. School staff should understand the condition and any limitations.
Does CMT1B affect the brain or intelligence?
No. Hereditary motor and sensory neuropathy Ib affects peripheral nerves, not the brain. Intelligence and memory are generally normal. People may feel tired or distracted because of pain or poor sleep, but the disease does not directly lower intelligence.
Is pregnancy safe for people with CMT1B?
Many women with CMT have healthy pregnancies and babies. However, pregnancy can temporarily worsen weakness or balance, and some medicines for neuropathic pain are not safe in pregnancy. Obstetric and neurology teams should plan pregnancy carefully.
Will my children inherit the disease?
CMT1B is often autosomal dominant, meaning each child of an affected parent has about a 50% chance of inheriting the mutation. Genetic counselling can explain the exact pattern in your family and discuss options such as prenatal or pre-implantation testing. NCBI+2Muscular Dystrophy Association+2
Can I stop wearing my braces when I feel better?
Braces help keep joints in good alignment and prevent falls, even when you feel stronger. Stopping them suddenly may increase injury risk. Any change in brace use should be discussed with your orthotist and physiotherapist.
Are over-the-counter painkillers enough?
Mild pain may respond to paracetamol or NSAIDs, but neuropathic pain often needs specific medicines like gabapentin, pregabalin, or duloxetine. Because of side effects and interactions, a neurologist or pain specialist should guide treatment. cmtausa.org+2PMC+2
Can vitamins or supplements cure my neuropathy?
No supplement has been proven to cure CMT1B. Some vitamins or antioxidants may support general nerve health, especially if you are deficient, but they are only add-ons to proper medical care and physiotherapy.
Is surgery always needed for foot deformities?
No. Many people do well with shoes, insoles, and AFOs alone. Surgery is considered when deformities are painful, progressive, or cause ulcers, and when conservative care is not enough. Orthopaedic surgeons with CMT experience are best placed to advise.
Can I join clinical trials?
Yes, in some countries there are registries and clinical trials for CMT. Joining a registry can help you hear about suitable research studies. Participation is always voluntary and comes with careful safety monitoring. PMC+3CMT Research Foundation+3Charcot-Marie-Tooth Disease+3
Does CMT1B shorten life expectancy?
Most people with hereditary motor and sensory neuropathy Ib have a near-normal life span, especially with good management of complications, foot care, and fall prevention. Quality of life can be high when pain, mood, and function are well supported.
What is the most important thing I can do right now?
The most important steps are to stay connected with a neuromuscular specialist, use physiotherapy and orthotics early, protect your feet, and look after your overall health (sleep, mood, weight, and other conditions). For a teenager, involving family, teachers, and a support group can make daily life much easier.

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.